Comment on CMS-2026-1255-0001

American Association of Nurse PractitionersSupportAdvocacy
Summary: The American Association of Nurse Practitioners (AANP) supports the proposed rule to streamline the prior authorization process for drugs through technology interoperability and standardized requirements. They argue that these measures will reduce administrative burdens on providers, improve patient access to medications, and increase transparency, while requesting specific protections against provider discrimination based on licensure.
Please see attached comments from the American Association of Nurse Practitioners

View on Regulations.gov